Logo image of MXL

MAXLINEAR INC (MXL) Stock Fundamental Analysis

NASDAQ:MXL - Nasdaq - US57776J1007 - Common Stock - Currency: USD

9.655  -1.36 (-12.31%)

After market: 9.75 +0.1 (+0.98%)

Fundamental Rating

3

Overall MXL gets a fundamental rating of 3 out of 10. We evaluated MXL against 109 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of MXL have multiple concerns. MXL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MXL has reported negative net income.
In the past year MXL has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MXL reported negative net income in multiple years.
MXL had a positive operating cash flow in 4 of the past 5 years.
MXL Yearly Net Income VS EBIT VS OCF VS FCFMXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

MXL's Return On Assets of -28.36% is on the low side compared to the rest of the industry. MXL is outperformed by 83.49% of its industry peers.
MXL has a Return On Equity of -47.49%. This is amonst the worse of the industry: MXL underperforms 82.57% of its industry peers.
Industry RankSector Rank
ROA -28.36%
ROE -47.49%
ROIC N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
MXL Yearly ROA, ROE, ROICMXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With a decent Gross Margin value of 54.03%, MXL is doing good in the industry, outperforming 76.15% of the companies in the same industry.
In the last couple of years the Gross Margin of MXL has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MXL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
MXL Yearly Profit, Operating, Gross MarginsMXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
MXL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MXL has more shares outstanding
MXL has a worse debt/assets ratio than last year.
MXL Yearly Shares OutstandingMXL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MXL Yearly Total Debt VS Total AssetsMXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MXL has an Altman-Z score of 1.02. This is a bad value and indicates that MXL is not financially healthy and even has some risk of bankruptcy.
MXL has a Altman-Z score of 1.02. This is in the lower half of the industry: MXL underperforms 73.39% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that MXL is not too dependend on debt financing.
MXL's Debt to Equity ratio of 0.24 is in line compared to the rest of the industry. MXL outperforms 40.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 1.02
ROIC/WACCN/A
WACC11.12%
MXL Yearly LT Debt VS Equity VS FCFMXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

A Current Ratio of 1.77 indicates that MXL should not have too much problems paying its short term obligations.
MXL has a worse Current ratio (1.77) than 77.06% of its industry peers.
MXL has a Quick Ratio of 1.28. This is a normal value and indicates that MXL is financially healthy and should not expect problems in meeting its short term obligations.
MXL has a Quick ratio of 1.28. This is in the lower half of the industry: MXL underperforms 77.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.28
MXL Yearly Current Assets VS Current LiabilitesMXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for MXL have decreased strongly by -568.75% in the last year.
MXL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.00%.
MXL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.59% yearly.
EPS 1Y (TTM)-568.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
Revenue 1Y (TTM)-48%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%0.69%

3.2 Future

MXL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.67% yearly.
Based on estimates for the next years, MXL will show a quite strong growth in Revenue. The Revenue will grow by 18.94% on average per year.
EPS Next Y140.62%
EPS Next 2Y72.6%
EPS Next 3Y50.67%
EPS Next 5YN/A
Revenue Next Year23.92%
Revenue Next 2Y21.81%
Revenue Next 3Y18.94%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MXL Yearly Revenue VS EstimatesMXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MXL Yearly EPS VS EstimatesMXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MXL. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 10.84, the valuation of MXL can be described as very reasonable.
MXL's Price/Forward Earnings ratio is rather cheap when compared to the industry. MXL is cheaper than 87.16% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MXL to the average of the S&P500 Index (21.65), we can say MXL is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 10.84
MXL Price Earnings VS Forward Price EarningsMXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MXL Per share dataMXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

MXL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MXL's earnings are expected to grow with 50.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.6%
EPS Next 3Y50.67%

More info and screens

0

5. Dividend

5.1 Amount

MXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXLINEAR INC

NASDAQ:MXL (4/24/2025, 8:27:23 PM)

After market: 9.75 +0.1 (+0.98%)

9.655

-1.36 (-12.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-22 2025-07-22/amc
Inst Owners85.92%
Inst Owner Change-2.78%
Ins Owners5.5%
Ins Owner Change-1.23%
Market Cap833.90M
Analysts72
Price Target18.92 (95.96%)
Short Float %6.95%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.83%
Min EPS beat(2)-10.24%
Max EPS beat(2)29.89%
EPS beat(4)2
Avg EPS beat(4)-0.87%
Min EPS beat(4)-27.3%
Max EPS beat(4)29.89%
EPS beat(8)5
Avg EPS beat(8)-2.22%
EPS beat(12)8
Avg EPS beat(12)-0.01%
EPS beat(16)12
Avg EPS beat(16)1.7%
Revenue beat(2)2
Avg Revenue beat(2)1.02%
Min Revenue beat(2)0.54%
Max Revenue beat(2)1.51%
Revenue beat(4)3
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-8.96%
Max Revenue beat(4)1.51%
Revenue beat(8)3
Avg Revenue beat(8)-2.11%
Revenue beat(12)4
Avg Revenue beat(12)-1.57%
Revenue beat(16)7
Avg Revenue beat(16)-1.02%
PT rev (1m)0%
PT rev (3m)11.69%
EPS NQ rev (1m)-2.13%
EPS NQ rev (3m)2.04%
EPS NY rev (1m)-1.08%
EPS NY rev (3m)3.98%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)1.76%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.84
P/S 2.31
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 5.84
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)0.89
Fwd EY9.23%
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS4.17
BVpS5.98
TBVpS1.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.36%
ROE -47.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.03%
FCFM N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
F-Score1
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 43.31%
Cap/Sales 6.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.28
Altman-Z 1.02
F-Score1
WACC11.12%
ROIC/WACCN/A
Cap/Depr(3y)51.53%
Cap/Depr(5y)53.82%
Cap/Sales(3y)5.32%
Cap/Sales(5y)5.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-568.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
EPS Next Y140.62%
EPS Next 2Y72.6%
EPS Next 3Y50.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-48%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%0.69%
Revenue Next Year23.92%
Revenue Next 2Y21.81%
Revenue Next 3Y18.94%
Revenue Next 5YN/A
EBIT growth 1Y-954.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year194.97%
EBIT Next 3Y56.1%
EBIT Next 5YN/A
FCF growth 1Y-771.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-204.43%
OCF growth 3YN/A
OCF growth 5YN/A